A0A2J8XPX9 (A0A2J8XPX9_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
N6-adenosine-methyltransferase non-catalytic subunit UniProtKBInterProInteractive Modelling
456 aa; Sequence (Fasta) ;
7 identical sequences: Homo sapiens: Q9HCE5; Pongo abelii: Q5R5N4; Pan troglodytes: H2QQ29, A0A6D2X6S1; Pan paniscus: A0A2R9A9D6; Gorilla gorilla gorilla: A0A2I2YEF1; Nomascus leucogenys: G1RC99
Available Structures
63 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structural of the METTL3-METTL14 complex for N6-adenosine methylation |
Heteromer Q86U44; Q9HCE5; | 100.0 | 2×EDO; 1×BR; | |||
| Crystal structure of SAH-bound METTL3-METTL14 complex |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SAH; 4×EDO; | |||
| Crystal structure of SAM-bound METTL3-METTL14 complex |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SAM; 3×EDO; | |||
| Structure of METTL3-METTL14(R298P) mutant methyltransferase complex |
Heteromer Q86U44; Q9HCE5; | 99.65 | ||||
| Crystal structure of the catalytic domains of Mettl3/Mettl14 complex |
Heteromer Q86U44; Q9HCE5; | 100 | ||||
| Crystal structure of the catalytic domain of Mettl3/Mettl14 complex with SAH |
Heteromer Q86U44; Q9HCE5; | 100 | 1×SAH; | |||
| Crystal structure of the catalytic domains of Mettl3/Mettl14 complex with SAM |
Heteromer Q86U44; Q9HCE5; | 100 | 1×SAM; | |||
| Structure of METTL3-METTL14(R298H) mutant methyltransferase complex |
Heteromer Q86U44; Q9HCE5; | 99.65 | ||||
| Structure of METTL3-METTL14(R298C) mutant methyltransferase complex |
Heteromer Q86U44; Q9HCE5; | 99.64 | ||||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 7 (ADO_AC_074) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UXK; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to SAH |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SAH; 1×MG; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ091 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×VAQ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 1/Adenosine (DHU_M3M_023) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×ADN; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ038 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×VAT; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 in complex with a bisubstrate analogue (BA4) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×I0C; 1×ACT; 1×MG; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 3 (ASI_M3M_138) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×NWW; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 4 (ASI_M3M_047) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×NWZ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 in complex with a bisubstrate analogue (BA2) |
Heteromer Q9HCE5; | 33.33 | 1×HZ2; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 in complex with a bisubstrate analogue (BA1) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×H9D; 1×ACT; 1×MG; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ004 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UE2; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ097 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×VA8; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 8 (ADO_AC_093) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×ACT; 1×UXW; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Sinefungin |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SFG; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to SAM |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SAM; 1×MG; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ016 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UE5; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ113 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×0BH; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 5 (ADO_AB_075) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UXE; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ059b |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×6IK; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 22 (UZH2) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UZ5; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ058 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEW; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ040a |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEE; 1×ACT; | |||
| METTL3-METTL14 heterodimer bound to the SAM competitive small molecule inhibitor STM3006 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×QWR; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ059a |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEQ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 15 (ADO_AE_026) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UY5; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 2 (ASI_M3M_140) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×NWQ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ090 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×V9T; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 17 (ADO_AE_005) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UYZ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ083 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×V9W; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ031 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEH; 1×ACT; 1×MG; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ094 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×0AE; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ019b |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×VB2; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ040b |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEE; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound T180 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×V0B; 1×ACT; | |||
| METTL3-METTL14 heterodimer bound to the SAM competitive small molecule inhibitor STM2457 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×V22; 1×DMS; | |||
| Human METTL3-METTL14 complex |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×SAH; 1×MG; 1×EDO; 8×UNX; 1×BME; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ019a |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×VB5; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound DHU_M3M_154 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UDW; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 19 (ADO_AE_009) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UZB; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 21 (ADO_AD_089) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UZH; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 20 (ADO_AD_044) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UZE; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 5 (ASI_M3M_051) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×NX8; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ078 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UEZ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 8 (ASI_M3M_091) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×NXB; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 9 (ADO_AD_023) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UXT; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 12 (ADO_AD_066) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UY2; 1×MG; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound T30 (UZH1a) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×R72; 1×MG; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 13 (ADO_AD_091) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UZ2; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound ASI_M3M_041 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UDQ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex bound to Compound 10 (ADO_AD_022) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×UXZ; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ002 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 4×MG; 1×UDK; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ120 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 4×MG; 1×VB8; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 in complex with a bisubstrate analogue (BA6) |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×H3I; 1×ACT; | |||
| Crystal structure of the human METTL3-METTL14 complex with compound UOZ111 |
Heteromer Q86U44; Q9HCE5; | 100.0 | 1×0BA; 1×ACT; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7rx7.1.B | monomer | 0.88 | 99.71 | |||